carvedilol (Coreg)
Title: carvedilol (Coreg)Category: MedicationsCreated: 1/16/2000 12:00:00 AMLast Editorial Review: 11/5/2018 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - November 5, 2018 Category: Cardiology Source Type: news

carvedilol (Coreg, Coreg CR)
Title: carvedilol (Coreg, Coreg CR)Category: MedicationsCreated: 1/16/2000 12:00:00 AMLast Editorial Review: 9/12/2018 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - September 12, 2018 Category: Cardiology Source Type: news

Carvedilol Helps Protect Heart During PPGL Surgery
(MedPage Today) -- Med offers superior blocking for cardiac complications in pheochromocytoma (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 23, 2018 Category: Cardiology Source Type: news

Teva Wins Reversal of U.S. Jury's $235 Mln GSK Drug Patent Verdict Teva Wins Reversal of U.S. Jury's $235 Mln GSK Drug Patent Verdict
A federal judge on Wednesday overturned a U.S. jury ' s verdict that required Teva Pharmaceutical Industries Ltd to pay GlaxoSmithKline Plc more than $235 million for infringing a patent covering its blood pressure drug Coreg.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 29, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Teva wins reversal of U.S. jury's $235 million GSK drug patent verdict
(Reuters) - A federal judge on Wednesday overturned a U.S. jury's verdict that required Teva Pharmaceutical Industries Ltd to pay GlaxoSmithKline Plc more than $235 million for infringing a patent covering its blood pressure drug Coreg. (Source: Reuters: Health)
Source: Reuters: Health - March 28, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Lisinopril and Carvedilol Reduce Cardiotoxicity in HER2+ Breast Cancer
Lisinopril and carvedilol reduced cardiotoxicity in patients with HER2-positive breast cancer treated with trastuzumab and anthracyclines. (Source: CancerNetwork)
Source: CancerNetwork - March 13, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer HER2-Positive Breast Cancer News Source Type: news

{beta}-Arrestin-biased {beta}-adrenergic signaling promotes extinction learning of cocaine reward memory
Extinction learning of cocaine-associated contextual cues can help prevent cocaine addicts from relapsing. Pharmacological manipulation of β-adrenergic receptor (β-AR) during extinction learning is being developed as a potential strategy to treat drug addiction. We demonstrated that the extinction learning of cocaine-associated memory was mediated by β-arrestin2–biased but not heterotrimeric guanine nucleotide–binding protein (G protein)–dependent β-adrenergic signaling. We found that administration of the nonbiased β-AR antagonist propranolol, but not the G protein–biased &...
Source: Signal Transduction Knowledge Environment - January 9, 2018 Category: Science Authors: Huang, B., Li, Y., Cheng, D., He, G., Liu, X., Ma, L. Tags: STKE Research Articles Source Type: news

Coreg vs. Metoprolol Tartrate
Title: Coreg vs. Metoprolol TartrateCategory: MedicationsCreated: 12/18/2017 12:00:00 AMLast Editorial Review: 12/18/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - December 18, 2017 Category: Drugs & Pharmacology Source Type: news

Impax Receives Tentative FDA Approval of Generic Coreg CR(R) (Carvedilol Phosphate) Extended-Release Capsules
BRIDGEWATER, N.J., Dec. 8, 2017 -- (Healthcare Sales & Marketing Network) -- Impax Laboratories, Inc. (NASDAQ: IPXL), a specialty pharmaceutical company, today announced it has received tentative U.S. Food and Drug Administration ("FDA") approva... Biopharmaceuticals, Generics, FDA Impax Laboratories, Coreg CR, carvedilol (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 8, 2017 Category: Pharmaceuticals Source Type: news

Do You Listen to Heart Sounds? This May be Another Reason Why You Should.
I’m not sure about you, but when I went to school to become a paramedic (and a nurse for that matter), one thing I never really understood was heart sounds, or heart tones, depending on who taught you. My attempt at learning resorted to scouring textbooks, journals, online editorials, watching clips on YouTube and listening… lots of listening to sound bites from CDs. You know the ones, they come free when you buy a new stethoscope. Instead of turning to digital media, I should’ve been listening to the hearts of my patients. Hindsight is 20/20, especially in this case. All my self-guided education yielded few results,...
Source: JEMS Patient Care - September 12, 2017 Category: Emergency Medicine Authors: Bruce Hoffman, MSN,BSN-RN, NR-P, CFRN Tags: Patient Care Cardiac & Resuscitation Source Type: news

GSK wins $235 million from Teva in Coreg patent trial
(Reuters) - A U.S. jury has ordered Teva Pharmaceutical Industries Ltd to pay GlaxoSmithKline Plc more than $235 million for infringing a patent covering its blood pressure drug Coreg, court documents showed. (Source: Reuters: Health)
Source: Reuters: Health - June 21, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Beta blocker shows cancer-fighting properties
A new study finds that carvedilol, a drug typically used to treat high blood pressure, can protect against the sun-induced cell damage that leads to skin cancer. The research could lead better ways to protect our skin from the sun. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 24, 2017 Category: Science Source Type: news

Beta blocker shows cancer-fighting properties
(Experimental Biology 2017) A new study finds that carvedilol, a drug typically used to treat high blood pressure, can protect against the sun-induced cell damage that leads to skin cancer. The research could lead better ways to protect our skin from the sun. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 23, 2017 Category: Cancer & Oncology Source Type: news

Coreg (Carvedilol) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 25, 2016 Category: Drugs & Pharmacology Source Type: news